1. Cabizuca M, Mendlowicz M, Marques-Portella C, Ragoni C, Coutinho ESF, Souza WF, et al. The invisible patients: posttraumatic stress disorder in parents of individuals with cystic fibrosis. Rev Psiq Clín 2010;37:6-11.
3. Writer BW, Meyer EG, Schillerstrom JE. Prazosin for military CombatRelated PTSD Nightmares: a critical review. J Neuropsychiatry Clin Neurosci 2014;26:24-33.
4. Kolk BA, Pelcovitz D, Roth S, Mandel FS, McFarlane A, Herman JL. Dissociation, somatization, and affect dysregulation: the complexity of adaptation of trauma. Am J Psychiatry 1996;153(7 Suppl):83-93.
5. Koenen KC, Ratanatharathorn A, Ng L, McLaughlin KA, Bromet EJ, et al. Posttraumatic stress disorder in the World Mental Health Surveys. Psychol Med 2017;47:2260-2274.
9. Schestatsky S, Shansis F, Ceitlin LH, Abreu PBS, Hauck S. Historical evolution of the concept of posttraumatic stress disorder. Braz J Psychiatry 2003;25(Suppl I):8-11.
10. Lifton RJ, Olson E. The human meaning of total disaster. The Buffalo Creek Experience. Psychiatry 1976;39:1-18.
11. Geracioti TD, Baker DG, Ekhator NN, West SA, Hill KK, Bruce AB, et al. CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry 2001;158:1227-1230.
12. Hendrickson RC, Raskind MA. Noradrenergic dysregulation in the pathophysiology of PTSD. Exp Neurol 2016;284:181-195.
13. Boehnlein JK, Kinzie JD. Pharmacologic reduction of CNS noradrenergic activity in PTSD: the case for clonidine and prazosin. J Psychiatr Pract 2007;13:72-78.
14. Lydiard RB, Hamner MH. Clinical importance of sleep disturbance as a treatment target in PTSD. Spring 2009;7:176-183.
15. Schoenfeld FB, Deviva JC, Manber R. Treatment of sleep disturbances in posttraumatic stress disorder: a review. J Rehabil Res Dev 2012;49:729-752.
16. Sjöström N, Hetta J, Waern M. Persistent nightmares are associated with repeat suicide attempt: a prospective study. Psychiatry Res 2009;170:208-211.
17. Liempt S, Vermetten E, Geuze E, Westenberg HGM. Pharmacotherapy for disordered sleep in posttraumatic stress disorder: a systematic review. Int Clin Psychopharmacol 2006;21:193-202.
19. George KC, Kebejian L, Ruth LJ, Miller CW, Himelhoch S. Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder. J Trauma Dissociation 2016;17:494-510.
20. Raskind MA, Dobie DJ, Kanter ED, Petrie EC, Thompson CE, Peskind ER. The alpha1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: a report of 4 cases. J Clin Psychiatry 2000;61:129-134.
21. Raskind MA, Thompson C, Petrie EC, Dobie DJ, Rein RJ, Hoff DJ, et al. Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder. J Clin Psychiatry 2002;63:565-568.
22. Taylor F, Raskind MA. The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder. J Clin Psychopharmacol 2002;22:82-85.
23. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane Handbook for Systematic Reviews of Interventions 2019 [version 6.0]. Available at:
www.training.cochrane.org/handbook.
24. Peskind ET, Bonner LT, Hoff DJ, Raskind MA. Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder. J Geriatr Psychiatry Neurol 2003;16:165-171.
25. Raskind MA, Peskind ER, Kanter ED, Petri EC, Radant A, Thompson C, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry 2003;160:371-373.
26. Taylor FB, Lowe K, Thompson C, McFall M, Peskind ER, Kanter ED, et al. Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder. Biol Psychiatry 2006;59:577-581.
27. Taylor FB, Martin P, Thompson C, Williams J, Mellman TA, Gross C, et al. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry 2008;63:629-632.
28. Raskind MA, Peskind ER, Hoff DJ, Hart KL, Holmes HA, Warren D, et al. A parallel group placebo-controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry 2007;61:928-934.
29. Germain A, Richardson R, Moul DE, Mammen O, Haas G, Forman GD, et al. Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US Military Veterans. J Psychosom Res 2012;72:89-96.
30. Raskind MA, Peterson K, Williams T, Hoff DJ, Hart K, Holmes H, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry 2013;170:1003-1010.
31. Ahmadpanaha M, Sabzeieea P, Hosseini SM, Torabian S, Haghighi M, Jahangard L, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology 2014;69:235-242.
32. De Berardis D, Marini S, Serroni N, Iasevoli F, Tomasetti C, de Bartolomeis A, et al. Targeting the noradrenergic system in posttraumatic stress disorder: a systematic review and meta-analysis of prazosin trials. Curr Drug Targets 2015;16:1094-1106.
34. Khachatryan D, Groll D, Booij L, Sepehry AA, Schütz CG. Prazosin for treating sleep disturbances in adults with posttraumatic stress disorder: a systematic review and meta-analysis of randomized controlled trials. Gen Hosp Psychiatry 2016;39:46-52.
35. Raskind MA, Peskind ER, Chow B, Harris C, Davis-Karim A, Holmes HA, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med 2018;378:507-517.
36. Glue P, Barak Y. Prazosin for post-traumatic stress disorder. N Engl J Med 2018;378:1649
37. McCall WV, Pillai A, Case D, McCloud L, Nolla T, Branch F, et al. A pilot, randomized clinical trial of bedtime doses of prazosin versus placebo in suicidal posttraumatic stress disorder patients with nightmares. J Clin Psychopharmacol 2018;38:618-621.
38. Singh B, Hughes AJ, Mehta G, Erwin PJ, Parsaik AK. Efficacy of prazosin in posttraumatic stress disorder: a systematic review and meta-analysis. Prim Care Companion CNS Disord 2016;18.
39. Green B. Prazosin in the treatment of PTSD. J Psychiatr Pract 2014;20:253-259.
40. Breen A, Blankley K, Fine J. The efficacy of prazosin for the treatment of posttraumatic stress disorder nightmares in U.S. military veterans. J Am Assoc Nurse Pract 2017;29:65-69.
41. Simon PY, Rousseau PF. Treatment of post-traumatic stress disorders with the alpha-1 adrenergic antagonist prazosin. Can J Psychiatry 2017;62:186-198.
42. Akinsanya A, Marwaha R, Tampi RR. Prazosin in children and adolescents with posttraumatic stress disorder who have nightmares: a systematic review. J Clin Psychopharmacol 2017;37:84-88.
45. Verplaetse TL, Ralevski E, Roberts W, Gueorguieva R, McKee SA, Petrakis IL. Alcohol abstainer status and prazosin treatment in association with changes in posttraumatic stress disorder symptoms in veterans with comorbid alcohol use disorder and posttraumatic stress disorder. Alcohol Clin Expl Res 2019;43:741-746.